GHRP-6
Animal studies onlyAlmost all the research is in animals. We do not know if the same thing happens in people.
Also called Growth Hormone Releasing Peptide 6 / SKF-110771
Similar to GHRP-2. Known for strongly increasing hunger in animal studies.
Can a doctor prescribe this?
No. It sits on a restricted list, so pharmacies are not allowed to make it.
The FDA has not approved this as a medicine.
The FDA has kept this in its restricted category. It was not part of the July 2026 review.
Official status: Category 2 – restricted from compounding. Checked 2026-04-15.
Lab suppliers we list: 10
Doses used in research
Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.
In animal studies
These are doses given to animals, usually per kilogram of body weight. They do not convert directly to a human dose.
0.4 mg/kg
rats · for 7 days
Growth Hormone-Releasing Peptide-6 (GHRP-6) Ameliorates Post-Infarct Ventricular Remodeling and Systolic Dysfunction in a Model of Permanent Coronary Ligation.Pharmaceuticals (Basel, Switzerland) · 2026
“Having determined 0.4 mg/kg as the minimum effective dose for enhancing inotropy based on echocardiographic parameters in healthy rats, we implemented a non-reperfusion myocardial infarct model, with its consequent left ventricle wall thinning and ballooning, via permanent left descending coronary artery ligation.”
See source wording
rats · another route · twice a day · for 7 days
Changes in Locomotor Activity Observed During Acute Nicotine Withdrawal Can Be Attenuated by Ghrelin and GHRP-6 in Rats.Biomedicines · 2025
“Methods: Male and female Wistar rats were exposed daily to intraperitoneal (ip) injection with 2 mg/kg nicotine or saline solution for 7 days, twice a day (at 8:00 and at 20:00).”
See source wording
dogs · into a vein · daily
Subchronic safety assessment of CIGB-500 in beagle dog after repeated daily dose administration over 28 days.Regulatory toxicology and pharmacology : RTP · 2025
“All animals were allocated to four groups: Control, Low-Dose (300 μg/kg/day), Mid dose (1000 μg/kg/day) and High-Dose (2000 μg/μg/day).”
5 mg/kg
rats · nasal spray
Intranasal Delivery of a Ghrelin Mimetic Engages the Brain Ghrelin Signaling System in Mice.Endocrinology · 2025
“Only GHRP-6 (5 mg/kg) increased food intake without adverse effects, prompting detailed analysis of meal patterns, neuronal activation in the arcuate nucleus (via Fos mapping) and neurochemical identification of c-fos messenger RNA (mRNA)-expressing neurons using RNAscope.”
300 nmol/kg
mice · daily · for 9 weeks
Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient mice.Atherosclerosis · 2020
“Methods From 4 to 19 weeks of age, male apoe -/- mice were fed a high fat high cholesterol (HFHC) diet, then switched to normal chow and treated daily with 300 nmol/kg of MPE-001 ([aza-Tyr 4 ]-GHRP-6) or MPE-003 ([aza-(N,N-diallylaminobut-2-ynyl)Gly 4 ]-GHRP-6) for 9 weeks.”
9 mg/kg
rats · for 5 days
Inhibition of Ghrelin Activity by Receptor Antagonist [d-Lys-3] GHRP-6 Attenuates Alcohol-Induced Hepatic Steatosis by Regulating Hepatic Lipid Metabolism.Biomolecules · 2019
“At 6 weeks, a subset of rats in each group were injected with either saline or ghrelin receptor antagonist, [d-Lys-3] GHRP-6 (DLys; 9 mg/kg body weight) for 5 days and all rats were sacrificed 2 days later.”
280 g
rats ·
Local injection of d-lys-3-GHRP-6 in the rat amygdala, dentate gyrus or ventral tegmental area impairs memory consolidation.Neuropeptides · 2018
“Adult male Wistar rats weighing 230-280g were used.”
200 nmol
mice ·
Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice.American journal of physiology. Regulatory, integrative and comparative physiology · 2018
“Our results showed that [d-Lys3]-GHRP-6 (200 nmol/mouse) reduced pulsatile growth hormone secretion and body fat mass as expected but worsened glucose and insulin intolerances and increased cumulative food intake unexpectedly.”
See source wording
mice ·
The effects of ghrelin antagonists [D-Lys(3) ]-GHRP-6 or JMV2959 on ethanol, water, and food intake in C57BL/6J mice.Alcoholism, clinical and experimental research · 2014
“Three experiments tested ghrelin antagonism using different doses; experiment 1 tested 12 mg/kg JMV2959; experiment 2 tested 15 mg/kg DLys; experiment 3 tested 9 mg/kg JMV2959.”
See source wording
fish · by mouth
“Experimental diets containing sAG (ranging from 0.001 to 13.04 µg/g) were prepared and fed to carp at 2.0 % of body weight (BW) in single-shot trials.”
See source wording
chickens ·
“In experiment 1, chicken injected with group 1 ICV injection of saline, group 2 with LEAP2 (0.75 nmol), group 3 with LEAP2 (1.5 nmol) and group 4 with LEAP2 (3 nmol).”
See source wording
fish · another route
“In this study, the effects of the ghrelin analog GHRP-6 peptide included in the diet (500 µg/kg of feed) on the endocrine and immune responses of Sparus aurata following Incomplete Freund's adjuvant (IFA) treatment were assessed.”
6 mg/kg
pigs · into a vein
“Growing pigs were intravenously injected with ghrelin receptor antagonist [D-Lys3]-GHRP-6 (DLys; 6 mg/kg body weight) for seven days to determine whether ghrelin plays a role in glucose and lipid metabolism.”
- Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.
Study in people
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2026
- Development and validation of a bioanalytical LC-MS method for the quantification of GHRP-6 in human plasma.
Study in people
Journal of pharmaceutical and biomedical analysis · 2012
- Growth hormone releasing peptide-6 (GHRP-6) ameliorates acute lung injury and its subsequent evolvement to interstitial fibrosis.
Animal study, rats or mice
International immunopharmacology · 2026
- Growth Hormone-Releasing Peptide-6 (GHRP-6) Ameliorates Post-Infarct Ventricular Remodeling and Systolic Dysfunction in a Model of Permanent Coronary Ligation.
Animal study, rats or mice
Pharmaceuticals (Basel, Switzerland) · 2026
- A discovery-based proteomic approach of epidermal growth factor and growth hormone-releasing peptide-6 in a model of acute ischemic stroke.
Animal study, rats or mice
Pharmacological reports : PR · 2026
- Activation of the nucleus nuclear factor erythroid 2-related factor 2ghrelin/growth hormone secretagogue receptor 1a signaling by Yueju pill confers cardioprotective and antidepressant effects.
Animal study, rats or mice
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2026
- The Ghrelin/GHSR-1a Axis Attenuates Preeclampsia-like Features with Decidual Macrophage Reprogramming and Improved Placental Remodeling.
Animal study, rats or mice
Biomolecules · 2026
- EGF and GHRP6 Co-Administration Attenuates Cognitive Decline in Preclinical Models: Behavioral and Molecular Evidences.
Animal study, rats or mice
Neurotoxicity research · 2026
- Ghrelin impairs embryo development after ovarian hyperstimulation.
Animal study, rats or mice
The Journal of endocrinology · 2026
- Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for acute kidney injury therapy via metabolic regulation.
Animal study, rats or mice
Journal of nanobiotechnology · 2025
- Changes in Locomotor Activity Observed During Acute Nicotine Withdrawal Can Be Attenuated by Ghrelin and GHRP-6 in Rats.
Animal study, rats or mice
Biomedicines · 2025
- Subchronic safety assessment of CIGB-500 in beagle dog after repeated daily dose administration over 28 days.
Dog study
Regulatory toxicology and pharmacology : RTP · 2025
- Intranasal Delivery of a Ghrelin Mimetic Engages the Brain Ghrelin Signaling System in Mice.
Animal study, rats or mice
Endocrinology · 2025
- Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms.
Animal study, rats or mice
Frontiers in pharmacology · 2024
- Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient mice.
Animal study, rats or mice
Atherosclerosis · 2020
- D-Lys-3-GHRP-6 impairs memory consolidation and downregulates the hippocampal serotonin HT1A, HT7 receptors and glutamate GluA1 subunit of AMPA receptors.
Animal study, rats or mice
Physiology & behavior · 2020
- Limited short-term effects on human prostate cancer xenograft growth and epidermal growth factor receptor gene expression by the ghrelin receptor antagonist [D-Lys<sup>3</sup>]-GHRP-6.
Animal study, rats or mice
Endocrine · 2019
- Inhibition of Ghrelin Activity by Receptor Antagonist [d-Lys-3] GHRP-6 Attenuates Alcohol-Induced Hepatic Steatosis by Regulating Hepatic Lipid Metabolism.
Animal study, rats or mice
Biomolecules · 2019
- Local injection of d-lys-3-GHRP-6 in the rat amygdala, dentate gyrus or ventral tegmental area impairs memory consolidation.
Animal study, rats or mice
Neuropeptides · 2018
- Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice.
Animal study, rats or mice
American journal of physiology. Regulatory, integrative and comparative physiology · 2018
- Impact of [d-Lys(3)]-GHRP-6 and feeding status on hypothalamic ghrelin-induced stress activation.
Animal study, rats or mice
Peptides · 2016
- The effects of ghrelin antagonists [D-Lys(3) ]-GHRP-6 or JMV2959 on ethanol, water, and food intake in C57BL/6J mice.
Animal study, rats or mice
Alcoholism, clinical and experimental research · 2014
- The effect of ghrelin antagonist (D-Lys3) GHRP-6 on ovariectomy-induced obesity in adult female albino rats.
Animal study, rats or mice
Endocrine regulations · 2014
- Gastric mucosal damage in water immersion stress: mechanism and prevention with GHRP-6.
Animal study, rats or mice
World journal of gastroenterology · 2012
- Protective effect of GHRP-6 and estrogen supplementation against some cardiometabolic risk factors in ovariectomized rats.
Animal study, rats or mice
Endocrine regulations · 2012
- Assessing The Effectiveness of Growth Hormone Releasing Protein-6 in Improving Human Oocyte Maturation and Meiotic Progression in <i>In Vitro</i> Maturation Culture Media.
Lab dish study
International journal of fertility & sterility · 2025
- Ghrelin antagonist D-Lys3-GHRP-6 counteract ghrelin effects in bovine cumulus-oocytes complexes matured in vitro.
Lab dish study
Reproduction in domestic animals = Zuchthygiene · 2021
- Potassium Current Is Not Affected by Long-Term Exposure to Ghrelin or GHRP-6 in Somatotropes GC Cells.
Lab dish study
Journal of biophysics (Hindawi Publishing Corporation : Online) · 2013
- Identification of ghrelin receptor blocker, D-[Lys3] GHRP-6 as a CXCR4 receptor antagonist.
Lab dish study
International journal of biological sciences · 2012
- The GHS-R blocker D-[Lys3] GHRP-6 serves as CCR5 chemokine receptor antagonist.
Lab dish study
International journal of medical sciences · 2012
- Oral salmon acylated ghrelin increases food intake in common carp (Cyprinus carpio) via ghrelin receptors, likely through sensory nerves rather than systemic absorption.
Peptides · 2026
- Anterior cervical osteophyte-related dysphagia in a long-term growth hormone user: a case report.
Frontiers in surgery · 2026
- Effect of intracerebroventricular (ICV) injection of antimicrobial peptide expressed in the body-2 (LEAP-2) and its interaction with cannabinoid and ghrelin systems on food intake in broiler chickens.
Poultry science · 2026
- The Ghrelin Analog GHRP-6, Delivered Through Aquafeeds, Modulates the Endocrine and Immune Responses of <i>Sparus aurata</i> Following IFA Treatment.
Biology · 2025
- Aza-Isotryptophan: Synthesis, Pictet-Spengler Chemistry, Incorporation and Conformational Analysis in Peptides, and Activity in Modulators of the Cluster of Differentiation-36 Receptor.
Journal of medicinal chemistry · 2025
- Inhibition of ghrelin activity by the receptor antagonist [D-Lys3]-GHRP-6 enhances hepatic fatty acid oxidation and gluconeogenesis in a growing pig model.
Peptides · 2023
- Assessment of dose-effect and therapeutic time window in preclinical studies of rhEGF and GHRP-6 coadministration for stroke therapy.
Neurological research · 2016
- Oral administration of the growth hormone secretagogue-6 (GHRP-6) enhances growth and non-specific immune responses in tilapia (Oreochromis sp.)
Aquaculture. · 2016
- Detection of GHRP-2 and GHRP-6 in urine samples from athletes.
Drug testing and analysis · 2015
- [D-Lys3]-GHRP-6 exhibits pro-autophagic effects on skeletal muscle.
Molecular and cellular endocrinology · 2015
- Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2013
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.
Review of earlier work
Frontiers in endocrinology · 2026